Clinical Trials Browser

Phase 1 × INDUSTRY × infigratinib × Clear all

NCT01928459 2020-12-09

Phase 1b Trial of BGJ398/BYL719 in Solid Tumors

Phase 1 Completed

Acrocephalosyndactylia, Breast Neoplasms

NCT01697605 2020-12-08

A Phase I Study of Oral BGJ398 in Asian Patients

Phase 1 Completed

Tumor With Alterations of the FGF-R

NCT01004224 2019-10-04

A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies

Phase 1 Completed

GenitourinaryThoracic

Urinary Bladder Neoplasms, Lung Neoplasms